On 18 December 2019, our new EUROIMMUN subsidiary in Japan was officially founded after one year of hard work, intensive planning and structuring. Head of this new subsidiary is Cagla Egretaud, who has been working at EUROIMMUN for 20 years. The idea to jointly establish a new subsidiary in Japan, one of the world’s largest […]
Whether a general health check, a preventive exam, or a test performed due to concrete complaints, many of us know these consultations at the doctor when a blood or tissue sample is collected for analysis and sent to a diagnostic laboratory. Some days, or even only hours later, the results are available and the physician
The construction works for the House of Engineers in Dassow started with the ground-breaking ceremony on 2nd July 2015. EUROIMMUN‘s company site was extended by a 4,000 m² building with a height of 16 m, 3.5 floors and a basement – the first one in the industrial area “Holmer Berg”. Moreover, 180 additional parking spaces
Press release Luebeck, August 9th, 2017 EUROIMMUN is pleased to announce that European Patent EP2514837 has been revoked in its entirety in opposition proceedings by the European Patent Office in their decision dated July 7, 2017. The claims of the patent as granted relate to a method for detecting brain damage caused by Alzheimer’s disease
Press release Luebeck, April 6th 2017 Today EUROIMMUN and Roche announced that they have entered into an option agreement under which Roche gains access to intellectual property in the field of Zika virus immunodiagnostics assigned to EUROIMMUN. In January 2016, EUROIMMUN became the first company in the world to launch antibody tests that are capable
